| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 02/09/2011 | CN101966150A Houttuynin derivative lipid microsphere preparation and preparation method thereof |
| 02/09/2011 | CN101966148A Injection composition comprising coenzyme Q10 and preparation method thereof |
| 02/09/2011 | CN101966143A Preparation and application of gatifloxacin temperature and pH sensitive ophthalmic gel |
| 02/09/2011 | CN101966134A Liquid soap with sterilizing and skin protecting functions and preparation method thereof |
| 02/09/2011 | CN101966131A Antimicrobial and antidandruff composition and application thereof |
| 02/09/2011 | CN101966129A Method for preparing artificial carbonated spring preparation |
| 02/09/2011 | CN101965810A Method for treating fish saprolegniasis by using methylene blue |
| 02/09/2011 | CN101463037B Method for synthesizing taspine |
| 02/09/2011 | CN101455819B Nutrient health product for treating chronic hepatitis B |
| 02/09/2011 | CN101422500B Immunoenhancement regulator of pig blue-ear disease vaccine and use thereof |
| 02/09/2011 | CN101391057B Medicine for preventing and treating porcine reproductive and respiratory syndrome |
| 02/09/2011 | CN101372490B Penem derivative containing sulfhydryl nitrogen heterocyclic ring and vinyl nitrogen heterocyclic ring |
| 02/09/2011 | CN101343272B Carbpenem compound containing cyclohexane |
| 02/09/2011 | CN101342251B Externally used medicament for treating scald head |
| 02/09/2011 | CN101341916B Cold tea for nourishing stomach |
| 02/09/2011 | CN101337011B Traditional Chinese medicine formulation for treating herpes circunata |
| 02/09/2011 | CN101328177B Nitrogen heterocyclic ring vinyl substituted sulfhydryl heterocycle carbpenem compounds |
| 02/09/2011 | CN101317904B Uses of smoked plum extract in resisting virus, bacteria, mycoplasma or chlamydia of livestock and poultry |
| 02/09/2011 | CN101280021B Engineered protein VP28-C against shrimp white spot syndrome virus, preparation and use thereof |
| 02/09/2011 | CN101274097B Atomizing grippe vaccine composition and preparation thereof |
| 02/09/2011 | CN101272793B Sphingomyelin-containing medicine, food and drink or fodder |
| 02/09/2011 | CN101272766B Composition for administration to mammals or humans |
| 02/09/2011 | CN101229235B Process for preparing corydalis saxicola bunting total alkali |
| 02/09/2011 | CN101128122B Fermented tea beverage and tea beverage |
| 02/09/2011 | CN101088553B Effective part of seesile stemona alkaloid and its application |
| 02/08/2011 | USRE42126 system for delivering oral care substance to oral cavity comprising a removable backing strip having sufficient flexibility to be conformable to oral surface and oral care composition that forms film when applied to backing strip comprising organosiloxane resin, rheology modifier, and oral care substance |
| 02/08/2011 | US7884198 The antibodies bind to whole bacteria and enhance phagocytosis and killing of the bacteria in vitro and enhance protection from lethal infection in vivo |
| 02/08/2011 | US7884070 for treating Cryptococcus infection in humans, animals, and plants |
| 02/08/2011 | US7883896 for early diagnosis, prognosis and monitoring of the disease course and for therapy and vaccination of cell proliferative disorders such as lung adenocarcinoma, lung carcinoma |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883713 Suspension, ointment, solution, spray, lotion, gel, cream, powder, powder spray, paste, emulsion, foam or stick; for treatment of herpes infections in humans |
| 02/08/2011 | US7883706 Methods for using Streptococcus pyogenes polypeptides |
| 02/08/2011 | CA2641585C Capsular polysaccharide solubilisation and combination vaccines |
| 02/08/2011 | CA2639651C Orally administered peptides to ameliorate atherosclerosis |
| 02/08/2011 | CA2559808C Spermicidal and virucidal properties of various forms of sophorolipids |
| 02/08/2011 | CA2529124C Antibiotic 107891, its factors a1 and a2, pharmaceutically acceptable salts and compositions, and use thereof |
| 02/08/2011 | CA2431461C 1,5 benzothiazepines and their use as antihyperlipidemics |
| 02/08/2011 | CA2419822C Modifications of hiv env, gag, and pol enhance immunogenicity for genetic immunization |
| 02/08/2011 | CA2350207C T cells specific for target antigens and methods and vaccines based thereon |
| 02/08/2011 | CA2341574C Phosphohalohydrins, method for making same and uses |
| 02/08/2011 | CA2328321C Combination vaccine for enhancing immunity against brucellosis |
| 02/08/2011 | CA2325566C Vaccine formulations comprising antiidiotypic antibodies which immunologically mimic group b streptococcal carbohydrates |
| 02/08/2011 | CA2314186C Adjuvanted vaccine comprising a cpg oligonucleotide and an antigen from streptococcus pneumoniae |
| 02/08/2011 | CA2296797C Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 02/08/2011 | CA2295971C Pseudomonas exotoxin a-like chimeric immunogens |
| 02/08/2011 | CA2284586C Aqueous immunologic adjuvant compositions of monophosphoryl lipid a |
| 02/08/2011 | CA2272240C Reductive alkylation of glycopeptide antibiotics |
| 02/08/2011 | CA2164226C Methods for selectively stimulating proliferation of t cells |
| 02/03/2011 | WO2011014882A1 CONTINUOUS SUBCUTANEOUS ADMINISTRATION OF INTERFERON-α TO HEPATITIS C INFECTED PATIENTS |
| 02/03/2011 | WO2011014776A1 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses |
| 02/03/2011 | WO2011014774A1 Nitroimidazooxazines and their uses in anti-tubercular therapy |
| 02/03/2011 | WO2011014487A1 Hepatitis c virus ns3 protease inhibitors |
| 02/03/2011 | WO2011014008A2 Novel 3-phenoxy-4-pyrone, 3-phenoxy-4-pyridone, or 4-pyridone derivatives, method for preparing same, and antimicrobial composition containing same as an active ingredient |
| 02/03/2011 | WO2011013992A2 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial |
| 02/03/2011 | WO2011013825A1 Antibacterial agent |
| 02/03/2011 | WO2011013735A1 Novel flavanone derivative |
| 02/03/2011 | WO2011013592A1 Coated preparation |
| 02/03/2011 | WO2011013494A1 Aqueous composition |
| 02/03/2011 | WO2011012698A2 Phthalocyanine derivative consisting of a mixture of 4 isomers |
| 02/03/2011 | WO2011012630A1 Substituted bis-aryl pyrazole amides having terminal primary amide functionalization for treating retroviral diseases |
| 02/03/2011 | WO2011012534A1 Plk inhibitor salts |
| 02/03/2011 | WO2011011971A1 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof |
| 02/03/2011 | WO2010129457A9 Vaccines against tularemia |
| 02/03/2011 | WO2010129233A9 Methods of treating bacterial infections using oritavancin |
| 02/03/2011 | WO2010128016A3 Par2 agonists for use in the treatment or prevention of influenza virus type a infections |
| 02/03/2011 | WO2010126839A3 Processed feeds, foods and biofuels and methods of making and using them |
| 02/03/2011 | WO2010111680A3 Dry powder formulations and methods for treating pulmonary diseases |
| 02/03/2011 | WO2010091294A9 New targeted antimicrobial moieties |
| 02/03/2011 | WO2010028796A8 Trispecific hexavalent antibodies |
| 02/03/2011 | WO2010025906A3 Hybrid antimicrobial compounds and their use |
| 02/03/2011 | US20110030108 Mammalian-type glycosylation in plants |
| 02/03/2011 | US20110028691 Recombinant toxin fragments |
| 02/03/2011 | US20110028566 Compositions and products containing cycloaliphatic diol antimicrobial agents and methods of using the compositions and products |
| 02/03/2011 | US20110028563 Anti-microbial composition |
| 02/03/2011 | US20110028560 Self-emulsifiable liquid florfenicol composition intended to be incorporated into the drinking water of livestock |
| 02/03/2011 | US20110028510 Compositions, Methods, and Kits for Treating Influenza Viral Infections |
| 02/03/2011 | US20110028507 Pyridine derivatives and methods of use thereof |
| 02/03/2011 | US20110028494 HCV NS3 Protease Inhibitors |
| 02/03/2011 | US20110028492 Heteroaryl Compounds and Their Uses |
| 02/03/2011 | US20110028487 Imidazopyrimidines and uses thereof |
| 02/03/2011 | US20110028485 1,5-diphenylpyrazoles ii as hsp90 inhibitors |
| 02/03/2011 | US20110028472 Thienopyrimidines |
| 02/03/2011 | US20110028469 Thiphene-2-Carboxamide Derivatives As Modulators of CCR9 Receptor |
| 02/03/2011 | US20110028466 Nitroimidazooxazine and nitroimidazooxazole analogues and their uses |
| 02/03/2011 | US20110028464 Inhibitors of human immunodeficiency virus replication |
| 02/03/2011 | US20110028444 Pharmaceutically acceptable salts of anti-infection quinolone compounds |
| 02/03/2011 | US20110028417 Macrocyclic Compounds and Methods of Use Thereof |
| 02/03/2011 | US20110028407 Enhancement of innate resistance to infection |
| 02/03/2011 | US20110028388 Double-stranded polyethylene glycol modified growth hormone, preparation method and application thereof |
| 02/03/2011 | US20110028387 METHODS OF SCREENING OF PP1-INTERACTING POLYPEPTIDES OR PROTEINS, PEPTIDES INHIBITING PP1c BINDING TO Bcl-2 PROTEINS, BCL-XL AND BCL-W, AND USES THEREOF |
| 02/03/2011 | US20110028386 Antimicrobial Peptides |
| 02/03/2011 | US20110028385 Combination of Immunomodulator and Anti-Pathogenic Agent |
| 02/03/2011 | US20110027883 Rna interference mediating small rna molecules |
| 02/03/2011 | US20110027399 Antiviral Agent and Antiviral Composition |
| 02/03/2011 | US20110027396 Novel milk thistle extract, method for the production, and use |
| 02/03/2011 | US20110027394 Cross-Linked Biopolymers, Related Compounds and Methods of Use |
| 02/03/2011 | US20110027389 Low Viscosity Liquid Polymeric Delivery System |
| 02/03/2011 | US20110027388 Cobalt Hexammine as a Potential Therapeutic Against HIV and/or Ebola Virus |
| 02/03/2011 | US20110027385 Nano-particle dispersions |
| 02/03/2011 | US20110027384 Photosensitising composition and its uses |